Dr. Heiko Schoder, MD
Claim this profileMemorial Sloan Kettering Cancer Center
Studies Hodgkin's Lymphoma
Studies Lymphoma
7 reported clinical trials
14 drugs studied
Area of expertise
1Hodgkin's Lymphoma
Stage III
Stage IV
2Lymphoma
Stage III
Stage IV
Affiliated Hospitals
Clinical Trials Heiko Schoder, MD is currently running
Pembrolizumab + GVD
for Hodgkin's Lymphoma
This trial is testing the combination of pembrolizumab and GVD chemotherapy in patients with Hodgkin lymphoma. Pembrolizumab boosts the immune system to fight cancer, and GVD directly kills cancer cells. Pembrolizumab has shown effectiveness in treating classical Hodgkin lymphoma, especially in patients who have relapsed after initial treatments.
Recruiting1 award Phase 219 criteria
[68Ga]-Pentixafor Imaging
for Blood Cancers
The purpose of this study is to determine the uptake of the imaging agent \[68Ga\]-pentixafor with PET/CT scans in people with monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma (SMM), and non-Hodgkin lymphoma (NHL), or you have histiocytic neoplasms (Langerhans cell histiocytosis (LCH), Erdheim-Chester disease (ECD) and/or Rosai-Dorfman disease (RDD).
Recruiting1 award Phase < 17 criteria
More about Heiko Schoder, MD
Clinical Trial Related7 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Heiko Schoder, MD has experience with
- 18F-FAC
- Olaparib
- Bleomycin
- Dacarbazine
- Doxorubicin
- Nivolumab
Breakdown of trials Heiko Schoder, MD has run
Hodgkin's Lymphoma
Prostate Cancer
Prostate Adenocarcinoma
Stomach Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Heiko Schoder, MD specialize in?
Heiko Schoder, MD focuses on Hodgkin's Lymphoma and Lymphoma. In particular, much of their work with Hodgkin's Lymphoma has involved Stage III patients, or patients who are Stage IV.
Is Heiko Schoder, MD currently recruiting for clinical trials?
Yes, Heiko Schoder, MD is currently recruiting for 2 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Heiko Schoder, MD has studied deeply?
Yes, Heiko Schoder, MD has studied treatments such as 18F-FAC, Olaparib, Bleomycin.
What is the best way to schedule an appointment with Heiko Schoder, MD?
Apply for one of the trials that Heiko Schoder, MD is conducting.
What is the office address of Heiko Schoder, MD?
The office of Heiko Schoder, MD is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.